Demirer, "A Review of myeloablative vs reduced intensity/non-myeloablative regimens in allogeneic hematopoietic stem cell
transplantations," Balkan Medical Journal, vol.
Caption: Figure 1: Myeloid progenitor and hematopoietic stem cell
populations are changed in Flt3-ITD mice.
Patients included in the study were those who (1) underwent hematopoietic stem cell
transplantation (allogeneic or autologous); (2) were [greater than or equal to] 18 years of age; (3) could understand, read, and write Turkish; (4) whose general condition made them eligible for participation in the study; and (5) agreed to participate in the study.
Pelletier, "Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell
transplants (HSCT): a qualitative study of their psychosocial experience," Journal of Pediatric Psychology, vol.
In comparison, GD 11.5 cells were initially analyzed to characterize the hematopoietic stem cells
before the differentiation potential was interrogated.
Daley's group directly tested the ability of blood flow to turn embryonic stem cells into hematopoietic stem cells
. The team placed mouse embryonic stem cells in a centrifuge-like device that mimics shear stress--the frictional force blood creates when it flows over cells--in a mouse's aorta.
CLT-001 in autoimmune disease Human and animal data show that many autoimmune diseases (lupus, Crohn's disease, rheumatoid arthritis, multiple sclerosis and type I diabetes) can be effectively treated with hematopoietic stem cells
from an allogeneic donor who does not have the disease.
In hematopoietic stem cell
and solid organ transplant recipients, infections with nontuberculous mycobacteria are common and may be a source of illness and death (3).
Omeros Corporation announced the recent presentation of a case report describing resolution of gastrointestinal hematopoietic stem cell
transplant-associated thrombotic microangiopathy following narsoplimab treatment under a compassionate-use protocol.
The European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending orphan drug designation for United States-based Omeros' OMS721 intended for treatment in hematopoietic stem cell
transplantation, it was reported yesterday.